Status:
RECRUITING
Persistent Post Surgical Pain After Total Knee Arthroplasty
Lead Sponsor:
Policlinico di Monza SpA
Conditions:
Knee Arthropathy
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Patients undergone total knee replacement are randomized to receive a "fast track" regional anesthesia protocol or a "traditional" regional anesthesia continuous infusion by both a femoral and sciatic...
Detailed Description
Patients undergone to primary total knee replacement with spinal anesthesia are randomized to receive a continuous adductor canal block infusion + an ipack block or a continuous femoral nerve block + ...
Eligibility Criteria
Inclusion
- primary total knee replacement with a written informed consent
Exclusion
- Allergy to local anesthetics or any drugs involve in the study
- Controindication to regional anesthesia
- chronic use of opioids
- BMI \> 35 kg m2
Key Trial Info
Start Date :
January 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
436 Patients enrolled
Trial Details
Trial ID
NCT06182059
Start Date
January 12 2024
End Date
July 31 2027
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico di Monza SPA
Monza, Monza Brianza, Italy, 20900